HomePaxlovid sales forecasts may change with Pfizer view on ChinaFILE PHOTO: Bourla, CEO of Pfizer gestures during a

FILE PHOTO: Bourla, CEO of Pfizer gestures during a

FILE PHOTO: Albert Bourla, CEO of Pfizer gestures during a discussion at the World Economic Forum (WEF) in Davos, Switzerland May 25, 2022. REUTERS/Arnd Wiegmann/File Photo

FILE PHOTO: Paxlovid is shown in this picture illustration

Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

January 27, 2025

Bitcoin drops to 11-day low amid tech selloff

January 27, 2025

Big Tech faces heat as China’s DeepSeek sows doubts on billion-dollar spending

January 27, 2025

Elon Musk says $1 million election giveaway wasn’t an illegal lottery

January 27, 2025

FILE PHOTO: Bourla, CEO of Pfizer gestures during a

Most Read

Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

Bitcoin drops to 11-day low amid tech selloff

Big Tech faces heat as China’s DeepSeek sows doubts on billion-dollar spending

Elon Musk says $1 million election giveaway wasn’t an illegal lottery

EDITOR PICKS

Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

Bitcoin drops to 11-day low amid tech selloff

Big Tech faces heat as China’s DeepSeek sows doubts on billion-dollar spending

POPULAR POSTS

Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO

Bitcoin drops to 11-day low amid tech selloff

Big Tech faces heat as China’s DeepSeek sows doubts on billion-dollar spending

POPULAR CATEGORY